Why Is MS a More Frequent Complication of EBV Infection in Females?

Area of Science:

• Neuroimmunology
• Sex Differences in Disease
• Viral Immunology

Background:

• Multiple sclerosis (MS) is a T helper cell-mediated autoimmune disease targeting CNS white matter.
• MS affects females three times more often than males, with unclear etiology.
• Epstein-Barr Virus (EBV) infection is a known trigger for MS, inducing cross-reactive immune responses.

Purpose of the Study:

• To review the literature on MS pathogenesis, focusing on sex differences.
• To explore the role of EBV in MS, particularly in relation to female susceptibility.
• To highlight the need for sex-disaggregated data in MS research.

Main Methods:

• Literature review of studies on MS, EBV, and sex differences.
• Analysis of EBV seroprevalence and infectious mononucleosis incidence in females.
• Examination of autoantibody and T cell responses in females with MS.

Main Results:

• Females exhibit higher EBV seroprevalence and infectious mononucleosis rates during peak MS susceptibility years.
• Females with MS show increased EBNA-1 cross-reactive autoantibodies and myelin-specific T helper 1 cells.
• EBV-infected B cells may establish greater latency in females, potentially perpetuating CNS autoimmunity.

Conclusions:

• Sex differences in EBV infection and immune responses contribute to MS pathogenesis.
• Understanding these sex-based mechanisms is crucial for developing targeted MS therapies.
• Future MS research must disaggregate data by sex to accelerate discoveries.